chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1st Dose=sore arm 2 days, pain in left hip joint; 1st Dose=sore arm 2 days, pain in left hip joint; Blisters on 3 toes of left foot started to form weekend prior to 2nd dose; This is a spontaneous report from a contactable Consumer (Patient). An 83-year-old non-pregnant female patient received first dose of bnt162b2 (COMIRNATY, solution for injection, Batch/Lot Number: er263), via an unspecified route of administration, administered left arm on 18Mar2021 at 15:15 and second dose of bnt162b2 (COMIRNATY, solution for injection, Batch/Lot Number: ew0158), via an unspecified route of administration, administered left arm on 08Apr2021 at 14:30, both as a single dose for COVID-19 immunization. Medical history included High Blood Pressure, Type 2 Diabetes, Degenerative Disc Disease, Spinal Stenosis and Arthritis. The patient had no allergies. Concomitant medications included Metformin, Amlodipine Besylate, Lisinopril. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 16:00, patient experienced with 1st Dose: sore arm 2 days, pain in left hip joint and with 2nd Dose: very tired-2days, sore arm 2 days and pain in left hip joint that radiated all the way down left leg and leg felt like it would give out. Blisters on 3 toes of left foot started to form weekend prior to 2nd dose. Painful to touch and felt like they were burning. The patient did not receive any treatment for the events. The outcome of events was recovering.  No follow-up attempts are needed; No further information is expected.
Yesterday I felt healthy and energetic. My left arm at the injection site turned very sore three hours later and I went to bed feeling achy (took three 81 mg aspirin), and woke up with a dull ache in my lower back, intermittent productive cough, malaise (even after seven hours of sleep), slight fever of 99F, watery eyes, and nasal congestion. When I had a bout with  influenza in November 1993 , this is how I recall it started. Now I know that the vaccine is "killed" virus and will not give me the flu, but I am quite uncomfortable. I have had four COVID-19 vaccines and am waiting to discern whether to get another because my doctor quit practicing medicine and I am without a trusted medical advisor at the moment.  I am really glad I did not get the flu and the next COVID vax at the same time because I also had reactions to every single one of the COVID vaxes. Thank you for allowing me to vent on this website.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. Patient's concurrent conditions and relevant medical history was not reported. Approximately on an unknown date in August 2010 (reported as 4 years ago), the patient was vaccinated with first dose of M-M-R II (dose unspecified) and experienced a seizure after administration of first dose. Concomitant medications were not reported. The outcome of seizure was unknown. The causality of the event with M-M-R II was not reported. Upon internal review, seizure was determined to be medically significant. Additional information is not expected.
Shortly after entering post vaccination area, client felt lightheaded and became diaphoretic.  VS 102/78-101-16; pulse ox 98% RA.  Had client lie down on stretcher.  VS 98/72-101-16; pulse ox 98% RA.  Stated he had not eaten anything for last several hours.  Client stated he felt much better and we sat him up, only for him to feel lightheaded again.  Had client lay back down.  Gave him crackers and juice.  After a short while VS 140/78-88-16; pulse ox 100% RA.  States he felt much better.  Refused any further treatment and was released to home.
started tingling on the right cheek on 1/22/2021, then it progressed to the right upper and lower lip, outside and inside, lateral eye corner of the eye and upper and lower eye lids, and then right ear fullness, pressure, ringing feeling.
This spontaneous case reported by a consumer, describes the occurrence of vaccination complication (severe reaction to the vaccine) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# unknown) for COVID-19 immunization. No medical history provided. On Feb 13, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced vaccination complication (severe reaction to the vaccine). At the time of the report, vaccination complication (severe reaction to the vaccine) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown.
This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm is sore) and PRURITUS (Arm is Itchy) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M2019) for COVID-19 vaccination.    No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm is sore) and PRURITUS (Arm is Itchy). At the time of the report, PAIN IN EXTREMITY (Arm is sore) and PRURITUS (Arm is Itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Patient had wanted to get Pfizer Vaccine, RN administered Moderna Vaccine instead, error occured when RN (self) was handed the Moderna Vaccine and the Patient was presented to me with the dose offered, I should have verbally clarified which vaccine patient would have liked to receive instead of assuming that the prefilled syringe that was handed to me was the correct one. Patient did not state her mention which vaccine she was there for, I presume she assumed the one handed to me was also the correct dose. Lack of Communication was/assuming/not clarifying and seeing the patient past our clinic closing time all contributed in an error being  made.  Patient left upset, but she did not have any symptoms. She was not aware that vaccines could be interchangeable.
Began with fussiness and emesis. Parents noted weak cry, generalized weakness, poor sleep, poor head control. Approx. 1 week following immunizations. Symptoms persisted and worsened. Dx with Guillain-Barre at hospital.
On 3/15/21 lips swelling took Benadryl Tagamet and Claritin 3/18/21 left side of face swollen throat closing up ER Benadryl, solucortef, Pepcid, epi 3/23, 3/24, 3/25 facial swelling throat closing up Benadryl prednisone epi 3/30/21 saw allergist  81 skin tests, 12 epidermal tests, blood tests all negative covid antibodies 121% and 176% diagnosed probable delayed adverse reaction to covid vaccine 4/15/21 joint and muscle pain and swelling  saw allergist referred to rheumatologist saw rheumatologist  and blood draws and X-rays on 5/3/21 started on plaaquenil saw rheumatologist on 5/17/21 histone antibodies 4.8 CRP 26.3 diagnosed with medication induced lupus  unknown if related to covid vaccine started on Celebrex and high dose vit d unable to work, get out of bed
I received my #2 vaccine at 6:55 PM on March 02, 2021.  I got up at about 2 AM March 03, with my left arm hurting rather badly.  I also got severe chills.  I went back to bed and about 30 minutes later, both the arm pain and chills were gone.  Neither has returned and I feel fine now.  It is now 09:50 PM March 03, 2021.
Reported having body aches, fever, headaches, light sensitivity on 4/20/18. Developed a couple of rash with fever on 4/21/18. On 4/22/18, had rash all over the face and the body, seen by personal provider, and diagnosed with chickenpox on 4/24/18.
Information has been received from a registered nurse for VARIVAX (Merck) and M-M-R II, a Pregnancy Registry product, concerning a 32 year old female with no drug reactions/allergies who on 14-JUN-2012, was vaccinated with a dose of VARIVAX (Merck) (lot # 1091AA, exp 06-JUL-2013) and on an unknown date, with a dose of M-M-R II (lot # 0512AA, exp 08-APR-2013) while pregnant. There ws no concomitant medication. No adverse effect was reported. The patient's LMP was son 25-APR-2012, EDD; 30-JAn-2013. The patient was exposed to VARIVAX (Merck) and M-M-R II during trimester 1. The patient had a urine and blood pregnancy tests. The patient saw the nurse. At the time of the report, the pregnancy outcome was unknown. No further information is available.
About 7:00pm, 4.5 hours was when we notice she was red and had hives, and the top of her legs were covered in hives, and there was small spotches on her lower legs too. Her torso, but after they gave her the steroid at urgent care, it cleared up. But it was mostly on her legs and arms. The doctors were surprised she did not have any breathing issues. This morning, she looks really good, there is nothing on her at all.  She was seen at Urgent Care.
Fever as high as 102F from 3 days post innoculation to seven days post innoculation.
FAMILY CALLED INTO CLINIC, VIS GIVEN AND WAS TOLD WHAT VACCINES THEY WOULD BE RECEIVING AND THAT IT WOULD BE THE LAST VACCINES REQUIRED BY IMMIGRATION, CLIENTS CALLED INTO ROOM AND VERIFIED ALLERGIES/HEALTH/LMP ETC PRIOR TO ADMINISTRATION OF VACCINES, CLIENTS FATHER HAD BANDAID TO ARM, WHEN WRITER ASKED REASON FOR BANDAID, CLIENT'S FATHER REPLIED "MY SON AND I RECEIVED A FLU VACCINE YESTERDAY FROM OUR JOB.  I SHOWED THE PAPER TO THE LADY OUT THERE", WRITE SPOKE WITH INTAKE WORKER WHO CONFIRMED WHAT CLIENTS FATHER PREVIOUSLY STATED BY SAYING, "YES THERE WAS 2 OF THEM AND I PUT THE FLU VACCINE ", AND SHE REQUESTED CLIENT ID NUMBERS AND STATED "I ENTERED THEM IN, BUT I DON'T KNOW WHY IT WAS NOT SAVED".  CLIENT DENIED ANY C/O DISCOMFORT, CALL MADE TO DR. AND INSTRUCTED TO EXPLAIN THE POSSIBLE S/E OF RECEIVING VACCINES IN INADVERTENLY 1 DAY APART, CLIENT EDUCATION PROVIDED VIA INTERPRETOR LINE, CLIENT VERBALIZIED UNDERSTANDING, COPY OF PAPERWORK COPIED AND PLACED IN CLIENTS FILE AS WELL AS VACCINE HX ENTERED INTO NCIR, SUPERVISOR MADE AWARE, WILL CONTINUE TO MONITOR.
COULD NOT SLEEP; SORE TO TOUCH; ACHE GOES FROM SHOULDER TO THE ELBOW; DULL ACHY PAIN THAT FELT LIKE DEEP IN THE MUSCLE OF THE SAME SIDE THAT WAS INJECTED; This spontaneous report received from a patient concerned a 61 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: non-alcohol user, and non-smoker, and other pre-existing medical conditions included: The patient had no known allergies. The patient did not have history of drug abuse or illicit drug use. The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: 207A21A, expiry: 21-SEP-2021) dose was not reported, administered on 07-SEP-2021 for prophylactic vaccination. No concomitant medications were reported. On SEP-2021, treatment medications included: paracetamol. On 21-SEP-2021, the patient experienced dull achy pain that felt like deep in the muscle of the same side that was injected. On 21-SEP-2021, the patient experienced sore to touch. On 21-SEP-2021, the patient experienced ache goes from shoulder to the elbow. On 23-SEP-2021, the patient experienced could not sleep. The action taken with covid-19 vaccine was not applicable. The patient was recovering from dull achy pain that felt like deep in the muscle of the same side that was injected, could not sleep, ache goes from shoulder to the elbow, and sore to touch. This report was non-serious.
Vx given after temp excursion 70°F aprox; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a neonate male patient who received HBV (Engerix B pediatric) (batch number XNFT7, expiry date 31-MAR-2024) for prophylaxis.   On 07-MAR-2023, the patient received Engerix B pediatric. On an unknown date, an unknown time after receiving Engerix B pediatric, the patient experienced incorrect storage of drug (Verbatim: Vx given after temp excursion 70°F aprox). The outcome of the incorrect storage of drug was unknown.   Additional Information: GSK receipt date: 7-Mar-2023 The pharmacist reported a temperature excursion for on Engerix-B pediatric dose.  This unique vaccine was left at room temperature, around 70 degree Fahrenheit approximately but not sure, for no more than 5 minutes with no prior excursions.  The reporter had no data about exact temperature reached.  After this situation, the vaccines was administered to a new born on the day of reporting. The reporter consented to follow-up. The patient received a dose of Engerix B pediatric after temperature excursion, which led to incorrect storage of drug. As the age was zero day at the time of vaccination and there is medication error therefore to avoid report failure only age group was captured as neonate.
Headache, pain in joints , lack of focus, lose of appetite,  lose of smell.
After roughly 3 hours my left shoulder muscles  started feeling weaker and started having mild pain but as time went on the pain got worse. As of today (3-16-21) my left shoulder muscles still have moderate pain when moving my arm.  I could also feel mild pain running up to the base  of my neck as well. Basically any left shoulder movement  still has some pain.
Patient started to feel dizzy for about one minute. His father states that patient was sitting up on a chair and he started to fall backward, so his father caught him and lowered him to the ground. He did not hit his head. He was not responsive for approximately 10 seconds, per the father. Clinical monitors arrived and patient was alert and oriented to name, place, date/time. He was slightly pale and clammy but he denied any dizziness, chest pain, palpitations, shortness of breath, headache, changes in his vision/hearing, or nausea.  He was laying on his back on the ground with his legs elevated on a chair and he started to feel better, and his blood pressure and oxygen saturation were stable with mild bradycardia per the vital signs obtained by one RN. He said he was feeling better and he was smiling and joking with staff. He slowly started to sit up and sipped bottled water. Stated that he had not eaten since 11am, and he agreed to a snack.  I left to get him a snack, and RN said that he started to "zone out" and he lost consciousness again for approximately 20 seconds. When I came back, he was sitting up, conscious, and had spit up saliva and water onto his shirt. His breathing was steady.   He again stated that he was feeling better very quickly, again in good spirits, but his father and I agreed that it would be best to call 911 to transport him to the ER just to be safe. He did not hit his head. He denied dizziness, chest pain, palpitations, shortness of breath, nausea, changes in vision,  and headache. He was alert and oriented to name, place, and time. EMS was requested and they arrived, took his vitals, and he was transported to the Emergency Dept for futher care.   He and his father were confident that he would recover quickly as he had a history of syncopal episodes related to vaccines in the past.
Low fever 14APR92 w/APAP (mom did not measure temp); pt felt warm to touch; no APAP given AM of 15APR92; t103 @ noon; APAP then given; by late afternoon t104.3 ax w/vomiting; seen by MD 5PM 15APR92; hospitalized 6PM 15APR92; MD advised DT;
severe chills and fatigue; severe chills and fatigue; I was bed ridden unable to get up or eat for 5 days; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A patient of unspecified age and gender received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 2 via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiry date was not reported) as dose 2, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number and Expiry date was not reported) for covid-19 immunization. On an unspecified date, the patient experienced severe chills and fatigue and i was bed ridden unable to get up or eat for 5 days. She wanted to thank for vaccine efforts and did not doubt it is saving lives. The patient stated that after receiving her 2nd shot, she experienced severe chills and fatigue and was bed ridden unable to get up or eat for 5 days. She experienced severe chills that lasted for 10 days and had moderate chills for 3 weeks. This is called a normal side effect. She further stated that you are obtaining approval for a 3rd round and she was seriously questioning her participation for a 3rd time. The clinical outcome of the events was unknown.  Information about Lot/Batch number is requested.
Swollen leg, limping, pain, crying to be held and refusing to walk. Fever of 99 degrees.
Administered only the liquid portion; Administered only the liquid portion; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate preparation of medication in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA712A, expiry date 31st May 2023) for prophylaxis.   On 6th September 2022, the patient received Menveo. On 6th September 2022, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK receipt date:06-Sep-2022 Reporters comment:  The Medical assistant administered only the liquid portion of Menveo. The reporter (HCP)gives permission for safety team follow up Additional Supportive information:The Medical assistant administered only the liquid portion of Menveo which led to inappropriate preparation of medication and inappropriate dose of vaccine administered
could not breath;could not speak out loud;dx w/bronchitis, laryngitis;eyes running w/thick fluid;hurt eyes-felt terrible, hurt all over;
Start: 10/2 @ 1800- burning/tingling of left eyelid Woke up 10/3 @ 0250- Left eye swollen completely shut, severe burning and irritation, mild swelling of right eye Current: 10/3 @0784- left eye swollen 3/4 shut, burning still present, right eye slightly swollen.
Sent home with fever 12/12, sick again 12/19 cough and congestion 12/21 showing fever and lethargic. 12/22 tested positive, didn't have Covid or flu. Currently on antibiotics.
COVID-19; COVID-19; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 48-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Dec2021 at 12:00 as dose 3 (booster), single (Lot number: FF8841) at the age of 47 years, in right arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "known allergies : Penicillin" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Cipro, reaction(s): "Allergy". The patient had no other medical history. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19 included Paxlovid from 17Oct2022 to 19Oct2022 for treatment of COVID-19.; Sender's Comments: Based on the information currently available, a causal association between the reported event COVID-19 and BNT162b2 cannot be excluded.
Last night around 8 PM my eyes began to itch and swell. They are swollen and red  today. They also pitch. Haven't  heard of this symptoms, but they are a definite reaction to the vaccine.
Severe pain in ALL upper and lower teeth  and moderate pain on bridge of nose lasting approximately 4 hours. My endodentist shared that 3 or 4 other patients had also reported severe pain in ALL of their teeth.  She also peppered that several colleagues had patients with similarities at pain after their Covid vaccinations.
Diagnosed with the Delta Variant after having the Moderna 2 shots; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Jan-2022 and was forwarded to Moderna on 16-Jan-2022.    This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Diagnosed with the Delta Variant after having the Moderna 2 shots) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Dec-2021, the patient experienced COVID-19 (Diagnosed with the Delta Variant after having the Moderna 2 shots). At the time of the report, COVID-19 (Diagnosed with the Delta Variant after having the Moderna 2 shots) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Dec-2021, SARS-CoV-2 test: positive (Positive) Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Company comment: This is a spontaneous case concerning a  female patient of an unknown age with no reported medical history, who experienced the non-serious event of special interest COVID-19. The events occurred on an unknown lapse of time after the second dose of mRNA-1273.  The benefit-risk relationship of mRNA-1273 is not affected by this report.   No concomitant medications were reported. Patient went to hospital and took antibody infusion on 16-DEC-2021.   This case was linked to MOD-2022-451756 (Patient Link).; Sender's Comments: Company comment: This is a spontaneous case concerning a  female patient of an unknown age with no reported medical history, who experienced the non-serious event of special interest COVID-19. The events occurred on an unknown lapse of time after the second dose of mRNA-1273.  The benefit-risk relationship of mRNA-1273 is not affected by this report.